Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia

被引：9
|
作者：
Ross, David M.
Jackson, Sharon R.
Browett, Peter J.
机构：
[1] Inst Med & Vet Sci, Div Hematol, Adelaide, SA 5000, Australia
[2] Middlemore Hosp, Dept Haematol, Auckland, New Zealand
[3] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand
来源：
LEUKEMIA & LYMPHOMA | 2007年 / 48卷 / 06期
关键词：
D O I：
10.1080/10428190701297360
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1231 / 1233
页数：3
相关论文
共 50 条
  • [1] Philadelphia-positive chronic-phase chronic myeloid leukaemia after long-term remission of Philadelphia-negative acute lymphoblastic leukaemia
    Nikolousis, Emmanouil
    Revell, Paul
    Novitzky-Basso, Igor
    Amos, Andrew
    ACTA HAEMATOLOGICA, 2008, 119 (02) : 124 - 125
  • [2] Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: Mobilization of Philadelphia-negative peripheral blood stem cells
    Chalmers, EA
    Franklin, IM
    Kelsey, SR
    Newland, AC
    Clark, RE
    Sproul, AN
    Crotty, G
    McCann, SR
    Fielding, A
    Goldstone, AH
    Hepplestone, A
    Watson, W
    Sharp, RA
    Tansey, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (03) : 627 - 634
  • [3] Imatinib mesylate in the treatment of chronic myeloid leukaemia
    Druker, BJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (06) : 963 - 971
  • [4] Characterisation of clonal Philadelphia-negative cytogenetic abnormalities in a large cohort of chronic myeloid leukaemia
    Chen, Xiangjun
    Zheng, Jine
    Liang, Kaiwei
    He, Yanli
    Du, Wen
    Li, Juan
    Liu, Wei
    Hu, Yanjie
    Huang, Shiang
    Yao, Junxia
    INTERNAL MEDICINE JOURNAL, 2018, 48 (04) : 439 - 444
  • [5] Philadelphia-negative clonal haematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukaemia
    de Melo, Valeria As
    Milojkovic, D.
    Khorashad, J. S.
    Marin, D.
    Goldman, J. M.
    Apperley, J. F.
    Reid, A.
    JOURNAL OF MEDICAL GENETICS, 2007, 44 : S32 - S32
  • [6] Imatinib or transplant for chronic myeloid leukaemia?
    Craddock, C
    Augustson, B
    Basu, S
    LANCET, 2003, 362 (9378): : 173 - 173
  • [7] Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia
    Daniels, J. M. A.
    Vonk-Noordegraaf, A.
    Janssen, J. J. W. M.
    Postmus, P. E.
    van Altena, R.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (03) : 670 - 672
  • [8] Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia
    Wahlin, A
    Golovleva, I
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 70 (04) : 240 - 241
  • [9] Central nervous system blastic phase in chronic myeloid leukaemia during imatinib treatment
    Kiss, A.
    Ujfalusy, A.
    Csepany, T.
    Remenyi, Gy.
    Batar, P.
    Balogh, E.
    Udvardy, M.
    BLOOD REVIEWS, 2007, 21 : S121 - S121
  • [10] Philadelphia-negative acute myeloid leukemia with new chromosomal abnormalities developing after first-line imatinib treatment for chronic phase chronic myeloid leukemia
    Fava, Carmen
    Cortes, Jorge
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (09) : 755 - 755
12345